Patent · US Active

Epstein-Barr virus-like particles with broadened antigenic spectrum

US11806395B2 · kind B2 · utility

0Cited by

5References

15Claims

0Family size

Assignee

Deutsches Krebsforschungszentrum · DE

Inventors

Henri-Jacques Delecluse · Heidelberg, DE
Dwain Van Zyl · Heidelberg, DE

Key dates

Filing date	Oct 11, 2019
Grant date	Nov 7, 2023
Priority date	—
Expiry date	Oct 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/16071
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a preparation comprising Epstein-Barr virus-like particles (EB-VLPs), said EB-VLPs being essentially free of Epstein Barr virus (EBV) DNA, wherein said EB-VLPs comprise a vaccination polypeptide comprising at least one peptide of an EBV tegument polypeptide and at least one immunogenic peptide; and to polynucleotides, host cells, and methods related thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.